Scaling a HealthTech company in Toronto is not just about building a better product or closing more pilots. It's about executing in a market where procurement is slow, evidence demands are high, and the path from pilot to paid adoption is rarely linear. Most HealthTech startups don't fail because their product doesn't work. They fail because pilot-stage execution doesn't survive contact with scale. If you're a HealthTech CEO in Toronto, your growth strategy has to do three th

Despite having world-class research institutions, a diverse population ideal for clinical trials, and growing investment interest, most healthtech startups in Toronto fail to scale beyond their initial pilot projects. This phenomenon isn't just frustrating for founders—it represents a systemic failure that costs our healthcare system access to potentially transformative technologies. Most Toronto HealthTech startups find it difficult to move beyond successful pilots due to a